iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAft, Forsyth & Company, Inc.
Latest Disclosed Ownership4,147 shares
Latest Disclosed Value $ 700,301
Aft, Forsyth & Company, Inc. reports 0.02% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Aft, Forsyth & Company, Inc. filed a 13F-HR form disclosing ownership of 4,147 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $700,301 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,146 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.02% during the quarter. The current value of the position is $543,464 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,147 1 0.02 700 0.14 0.3297
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,146 -17 -0.41 700 16.50 0.3019
2025-11-07 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,163 -43 -1.02 601 12.78 0.2879
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,206 -5 -0.12 532 -1.12 0.2726
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,211 2 0.05 539 -3.24 0.2901
2025-01-29 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,209 -153 -3.51 556 -12.44 0.2729
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,362 -32 -0.73 635 5.31 0.3131
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,394 30 0.69 603 0.84 0.2957
2024-04-30 2024-03-31 13F ISHARES TR ETF 464287556 4,364 108 2.54 599 3.46 0.3412
2024-02-09 2023-12-31 13F ISHARES TR ETF 464287556 4,256 -387 -8.34 578 1.94 0.3638
2023-11-07 2023-09-30 13F ISHARES TR ETF 464287556 4,643 -5 -0.11 568 -3.90 0.4161
2023-08-14 2023-06-30 13F ISHARES TR ETF 464287556 4,648 -385 -7.65 590 -9.23 0.4184
2023-05-02 2023-03-31 13F ISHARES TR ETF 464287556 5,033 56 1.13 650 -0.46 0.5021
2023-02-13 2022-12-31 13F ISHARES TR ETF 464287556 4,977 141 2.92 653 15.37 0.5573
2022-11-14 2022-09-30 13F ISHARES TR ETF 464287556 4,836 115 2.44 566 1.98 0.5051
2022-07-28 2022-06-30 13F ISHARES TR ETF 464287556 4,721 1 0.02 555 -9.76 0.4479
2022-05-10 2022-03-31 13F ISHARES TR ETF 464287556 4,720 -68 -1.42 615 -15.87 0.3917
2022-02-07 2021-12-31 13F ISHARES TR ETF 464287556 4,788 31 0.65 731 -4.94 0.3751
2021-11-08 2021-09-30 13F ISHARES TR ETF 464287556 4,757 60 1.28 769 0.00 0.4131
2021-07-15 2021-06-30 13F ISHARES TR ETF 464287556 4,697 65 1.40 769 10.33 0.4106
2021-05-04 2021-03-31 13F ISHARES TR ETF 464287556 4,632 30 0.65 697 0.00 0.4179
2021-02-09 2020-12-31 13F ISHARES TR ETF 464287556 4,602 95 2.11 697 14.26 0.4360
2020-11-05 2020-09-30 13F ISHARES TR ETF 464287556 4,507 331 7.93 610 6.83 0.4539
2020-08-06 2020-06-30 13F ISHARES TR ETF 464287556 4,176 75 1.83 571 29.48 0.4815
2020-05-11 2020-03-31 13F ISHARES TR ETF 464287556 4,101 -53 -1.28 442 -11.98 0.4444
2020-02-10 2019-12-31 13F ISHARES TR ETF 464287556 4,154 125 3.10 501 24.94 0.3824
2019-11-12 2019-09-30 13F ISHARES TR ETF 464287556 4,029 -120 -2.89 401 -11.48 0.3312
2019-07-29 2019-06-30 13F ISHARES TR ETF 464287556 4,149 0 0.00 453 -2.37 0.3731
2019-05-08 2019-03-31 13F ISHARES TR ETF 464287556 4,149 0 0.00 464 16.00 0.4019
2019-02-05 2018-12-31 13F Ishares Nasdaq Bio Fd ETF 464287556 4,149 -90 -2.12 400 -22.63 0.3982
2018-10-26 2018-09-30 13F ISHARES TR ETF 464287556 4,239 0 0.00 517 10.94 0.4288
2018-08-14 2018-06-30 13F Ishares Nasdaq Bio Fd ETF 464287556 4,239 -90 -2.08 466 0.87 0.4088
2018-05-14 2018-03-31 13F Ishares Nasdaq Bio Fd ETF 464287556 4,329 0 0.00 462 0.00 0.4312
2018-02-12 2017-12-31 13F Ishares Nasdaq Bio Fd ETF 464287556 4,329 3,701 589.33 462 250.00 0.4522
2013-11-08 2013-09-30 13F Ishares Nasdaq Bio Fd ETF 464287556 628 248 65.26 132 100.00 0.1712
2013-08-12 2013-06-30 13F Ishares Nasdaq Bio Fd ETF 464287556 380 380 66 0.0943
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.